Italia markets close in 6 hours 23 minutes
FTSE MIB
27.964,65 -47,65 (-0,17%) Dow Jones
33.550,27 -68,63 (-0,20%) Nasdaq
13.092,85 +29,25 (+0,22%) Nikkei 225
31.872,52 -499,38 (-1,54%) Petrolio
93,82 +0,14 (+0,15%) Bitcoin EUR
25.079,83 +131,63 (+0,53%)
BLUE Jan 2025 15.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Al 11:46AM EDT. Mercato aperto.
| Chiusura precedente | 0,3500 |
| Aperto | 0,3500 |
| Denaro | 0,0000 |
| Lettera | 0,0000 |
| Prezzo d'esercizio | 15,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 0,3500 - 0,3500 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | N/D |
GlobeNewswireReal Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem
© 2023 Yahoo. Tutti i diritti riservati.
